After hyaluronan and doxorubicin co-treatment, hyaluronan altered drug accumulation and modulated the expression of ATP-binding cassette transporters in T-cell lymphoma cells. This evidence concerns the gene ABCA4 and T-cell non-Hodgkin lymphoma.